Press release - 08/01/2015 Biotech-Cluster Rhine-Neckar (BioRN) leads InnoLife consortium to success BioRN is a member of the consortium InnoLife, which has won the call for the Knowledge and Innovation Community (KIC) Healthy Living and Active Ageing (EIT Health) of the European Institute for Innovation and Technology (EIT). With a grant volume of up to 700 million euros and a total project volume of more than 2 billion euros, this is one of the largest publicly funded initiatives in the health sector worldwide.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biotech-cluster-rhine-neckar-biorn-leads-innolife-consortium-to-success
Article - 22/12/2014 Bioinformaticians shed light into the data jungle In recent years, the University of Tübingen has developed a tightly integrated service structure for the computer-based management of life sciences data. This structure is the point of contact for all those that produce or work with “omics” data – in Tübingen and beyond.https://www.gesundheitsindustrie-bw.de/en/article/news/bioinformaticians-shed-light-into-the-data-jungle
Article - 13/10/2014 Data mining is likely to play an increasing role in clinical development Data mining still plays a minor role in the research-based pharmaceutical industry. But this is likely to change in the future. Mathematician Hans-Jürgen Lomp predicts that exploratory data analysis will be used to a greater extent in the future. Lomp is the Global Head of Statistics in Boehringer Ingelheim Pharma GmbH & Co KG’s Department of Medical Data Service and Biostatistics in Biberach.https://www.gesundheitsindustrie-bw.de/en/article/news/data-mining-is-likely-to-play-an-increasing-role-in-clinical-development
Part 2 - 06/10/2014 Expert interview: How are the prices of innovative diagnostic and medical devices determined? While there are specific regulations in Germany for the reimbursement of medicines, funding for molecular diagnostics products is complex and virtually non-existent. There is hardly any medical insurance cover for medical devices, which therefore tend to be sold on the open market. The question therefore arises as to how a reasonable price can be determined for innovative diagnostic methods and tools. In the second part of the interview conducted…https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-innovative-diagnostic-and-medical-devices-determined
Article - 29/09/2014 myPOLS Biotec UG - made-to-measure enzymes for diagnostics and research The company myPOLS Biotec UG, a spin-off from the University of Konstanz, specializes in services involving DNA and RNA polymerases and creates artificial enzymes by evolution in test tubes. These next-generation polymerases can be used for many research and diagnostics applications. myPOLS Biotec’s polymerases are promising enzymes for future applications with the potential to make the detection of pathogens and DNA analysis faster and easier. https://www.gesundheitsindustrie-bw.de/en/article/news/mypols-biotec-ug-made-to-measure-enzymes-for-diagnostics-and-research
Part 1 - 22/09/2014 Expert interview: How are the prices of new pharmaceuticals determined? Healthcare in Germany is quite good. Pharmaceutical and biotechnology companies carry out research in order to improve it further. The question is, how can a fair price for innovative drugs be determined? BIOPRO Baden-Württemberg GmbH has talked to Dr. Manfred Caeser, a specialist in pricing and reimbursement at LSCN Ltd.https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-new-pharmaceuticals-determined
Press release - 04/06/2014 Coordination office for telemedicine-assisted healthcare network The Baden-Württemberg Ministry of Science Research and the Arts is supporting the establishment of a state-wide coordination office for a Central Innovative Telemedicine-Assisted Healthcare Network in Baden-Württemberg with funds totalling 600000 euros for a period of five years. The office will be located in Mannheim and according to Research Minister Theresia Bauer it will make a significant contribution to boosting the quality and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/coordination-office-for-telemedicine-assisted-healthcare-network
Article - 26/05/2014 HDC – state-of-the-art drug research at a location with a long-standing tradition Hit Discovery Constance GmbH (HDC) searches for new drug candidates on behalf of academic institutions and the pharmaceutical industry. Established in early 2014 on the Konstanz Campus (former Takeda/Nycomed/Altana research site), the joint venture organization offers high-throughput screening and compound management and storage services to support the transfer of academic research into the development of new medicines. With its high-throughput…https://www.gesundheitsindustrie-bw.de/en/article/news/hdc-state-of-the-art-drug-research-at-a-location-with-a-long-standing-tradition
Press release - 26/05/2014 50 years of research for life without cancer The German Cancer Research Center (DKFZ) in Heidelberg turns 50 this year. Conducting research on the basic biological mechanisms of cancer, the DKFZ has been instrumental in our current understanding of the development and growth of cancer and has advanced the development of enhanced methods for the prevention, diagnosis and treatment of cancer. https://www.gesundheitsindustrie-bw.de/en/article/press-release/50-years-of-research-for-life-without-cancer
Article - 28/04/2014 Sciomics: antibody microarrays and their broad range of applications Sciomics GmbH is a start-up biotech from Heidelberg with a special focus on protein microarrays. Sciomics produces complex, high-density antibody microarrays for cancer-relevant proteins and offers services for medical research, diagnostics and the industry, including biomarker screening, the verification of biomarker candidates, the analysis and localization of drug targets and their signalling pathways as well as the characterization of…https://www.gesundheitsindustrie-bw.de/en/article/news/sciomics-antibody-microarrays-and-their-broad-range-of-applications
Press release - 31/03/2014 Universal Biotech: Call for Proposals for the 6. Innovation Prize 2014 The Innovation Prize 2014 aims to promote innovation in the field of biotechnology. It targets medicines, medical devices, medical technologies and e-health solutions. The Innovation Prize is open to Academic researchers in the field of Life Sciences and Representatives from young companies. The winner will receive a reward of a combined value of 50,000€ including cash and consulting services provided by Universal Biotech during one year after…https://www.gesundheitsindustrie-bw.de/en/article/press-release/universal-biotech-call-for-proposals-for-the-6-innovation-prize-2014
Article - 10/03/2014 INCIDE – IT solutions in the life sciences The use of modern research methods in the natural sciences generates increasing amounts of data, which can often only be analysed using special software. The INCIDE research centre at the University of Konstanz provides data processing services that facilitate the development and adaptation of software programmes for use in the life sciences. The INCIDE scientists work in close collaboration with life scientists. In future, this successful…https://www.gesundheitsindustrie-bw.de/en/article/news/incide-it-solutions-in-the-life-sciences
Guest article - 31/01/2014 Experience report: internship at Boehringer Ingelheim in Shanghai A scholarship from the Baden-Württemberg Ministry of Science, Research and the Arts enabled Henrik Baran to do an internship at Boehringer Ingelheim Pharma GmbH and Co. KG in Shanghai. From March to August 2013, Henrik worked in the company's Global Biopharma Engineering & Technology department where he was involved in cleanroom planning. He was also project coordinator in charge of redeveloping company premises. Here he summarises his…https://www.gesundheitsindustrie-bw.de/en/article/news/experience-report-internship-at-boehringer-ingelheim-in-shanghai
Press release - 15/01/2014 Hit Discovery Constance GmbH: a new hub for HTS and compound management Hit Discovery Constance GmbH (“HDC”), a new joint venture organisation between Lead Discovery Center (Dortmund/Germany), Centre for Drug Design and Discovery (CD3, KULeuven, Leuven/Belgium) and Axxam (Milan/Italy) has started its operation. The new company is based in Constance (Germany) and will make use of the already established equipment and know-how of the former Takeda/Nycomed/Altana screening and compound management facilities at the site.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hit-discovery-constance-gmbh-a-new-hub-for-hts-and-compound-management
Article - 09/12/2013 KVART – a hospital bed with built-in intelligence Exercise is the best medicine! this was the maxim adopted by Dr. Clemens Gutknecht and Dr. Josef Schönberger when they were investigating the treatment remobilisation and care of bedridden patients. The findings of the two experienced neurologists led to the development of a concept for an intelligent hospital bed. Based on a patented technology and quantitative market potential estimates Gutknecht and Schönberger have established KVART GmbH in…https://www.gesundheitsindustrie-bw.de/en/article/news/kvart-a-hospital-bed-with-built-in-intelligence
Article - 25/11/2013 GlucoChat: a communication platform for the treatment of young patients with type I diabetes The idea of being able to access a secure and relatively straightforward way of communicating with others as part of a social network definitely appeals to those who live several hundred kilometres away from a specialist doctor. However, data protection issues present a number of difficulties. careon, an e-health company from Tübingen, has found a solution by developing a platform for social network applications in which data remains…https://www.gesundheitsindustrie-bw.de/en/article/news/glucochat-a-communication-platform-for-the-treatment-of-young-patients-with-type-i-diabetes
Press release - 20/11/2013 State affiliate BIOPRO Baden-Württemberg supports the local medical engineering industry State affiliate BIOPRO Baden-Württemberg, an agency focussing on medical engineering, biotechnology and pharmaceuticals in Baden-Württemberg, presents itself at MEDICA. Find us at the Baden-Württemberg joint booth (hall 16 C41) to obtain information about our region. The recently published industry report “Healthcare Industry 2013, Facts and Figures for Baden-Württemberg” containing current data on medical engineering as well as a biotech guide…https://www.gesundheitsindustrie-bw.de/en/article/press-release/state-affiliate-biopro-baden-wuerttemberg-supports-the-local-medical-engineering-industry
Article - 18/11/2013 The HAE Accelerator – "compete to speed up your start-up" The HAE Accelerator is an international programme involving biomedical clusters in Cambridge (UK), Leuven (Belgium) and Heidelberg (Germany) that seeks to identify, train and put innovative start-up teams in the three countries in contact with international VC investors. Of the three business ideas that were awarded a HAE Investors’ Choice Award in September 2013, InoCard from Heidelberg came first with a new gene therapy for myocardial…https://www.gesundheitsindustrie-bw.de/en/article/news/the-hae-accelerator-compete-to-speed-up-your-start-up
Article - 18/11/2013 Insilico Biotechnology AG: strategic orientation secures corporate growth Insilico Biotechnology AG from Stuttgart designs and optimises biotechnological processes for the chemical pharmaceutical and food industries. The company makes predictions on the behaviour of cells and organisms. This knowledge can be used to reduce the time required for the development or optimisation of biotechnological processes involving the production of drugs. The company owns a worldwide unique systems biology platform that integrates…https://www.gesundheitsindustrie-bw.de/en/article/news/insilico-biotechnology-ag-strategic-orientation-secures-corporate-growth
Article - 11/11/2013 Vitaphone GmbH - innovative telemedicine Vitaphone GmbH from Mannheim is a leading international telemedical service provider. Its services range from telecardiological functional diagnostics, 24/7 telemonitoring of risk patients to integrative care management of chronically ill patients. Vitaphone is particularly involved in the application of structured telemonitoring-based therapy programmes for patients with heart failure. https://www.gesundheitsindustrie-bw.de/en/article/news/vitaphone-gmbh-innovative-telemedicine
Press release - 16/10/2013 BIOTECHNICA 2013 - Baden-Württemberg is a top life sciences spot. The BIOTECHNICA trade show rolled out the red carpet for its exhibitors. Over 10,000 visitors walked over the carpet to inspect the exhibits that were on display at the Baden-Württemberg booth. The impressive exhibits of the companies showed that Baden-Württemberg has many highly innovative SMEs in the life sciences field. https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnica-2013-baden-wuerttemberg-is-a-top-life-sciences-spot
Article - 16/09/2013 Infrared light as an indicator of wine quality Guaranteeing the quality of wines is becoming increasingly important so that they are able to compete in the international market. However, the quality control methods currently used are often rather time-consuming and costly. In addition, it is difficult to detect microbial grape contaminations that might jeopardise the quality of the wines. Researchers at the National Training and Research Institute for Viticulture and Horticulture in…https://www.gesundheitsindustrie-bw.de/en/article/news/infrared-light-as-an-indicator-of-wine-quality
Article - 19/08/2013 Fraunhofer IPA – mobile emergency assistant prepares for the marketplace The Fraunhofer Institute for Manufacturing Engineering and Automation IPA has developed MobiNa a mobile emergency assistant to deliver external support to elderly and infirm people. MobiNa will enable them to stay in their own homes as long as possible where they can lead an independent life. MobiNa assists its owner not only as a reliable helper in emergency situations but also as a continuously-available mobile communication system.https://www.gesundheitsindustrie-bw.de/en/article/news/fraunhofer-ipa-mobile-emergency-assistant-prepares-for-the-marketplace
Dossier - 19/08/2013 Telemedicine: advances in high-tech healthcare Increasing average longevity, the growing number of chronic diseases and health economy issues are all generating an ever-increasing demand for inexpensive therapy options that are not time- or location dependent. For the past 10 years or so, telemedicine has been offering advanced solutions for a broad range of medical and health issues. Despite this progress, the use of telecommunication and information technologies in the provision of remote…https://www.gesundheitsindustrie-bw.de/en/article/dossier/telemedicine-advances-in-high-tech-healthcare
Article - 12/08/2013 A complete exome sequence in one week The exome is the part of the genome that is formed by exons i.e. the DNA regions that code for proteins and other functional products. Though comprising only about 1 of the total genome the majority of disease-causing mutations occur in the exome. Selectively sequencing the coding regions of the genome is quicker than whole-genome sequencing. Therefore exome sequencing plays an important role in the diagnosis of genetic diseases and cancer.…https://www.gesundheitsindustrie-bw.de/en/article/news/a-complete-exome-sequence-in-one-week